Health
Revolution Medicines gets FDA nod for targeted pancreatic cancer drug
Headline as filed by CNBC Top News. PageNews does not write or rewrite headlines.
PageNews Brief
One publisher, CNBC Top News, has reported this so far, at 15:51 UTC on 26 August 2026.
No other outlet PageNews follows has covered it. If one files, their report will be added to this page and the comparison below will fill out.
The coverage is filed under Health. The publisher's own headline, summary and link is below.
Compiled by PageNews from the report listed below — who filed it and when. No publisher wrote this section.
Coverage from 1 publisher
-
CNBC Top News
Revolution Medicines gets FDA nod for targeted pancreatic cancer drug
The drug is a once-daily pill designed to block several forms of the RAS protein, which helps drive tumor growth in many pancreatic cancers.
Read on CNBC Top News →
Reader comments
Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.
Nobody has commented on this story yet.